Dashboard K. pneumoniae
Repurposing candidates for K. pneumoniae
Klebsiella pneumoniae
Approved medicines with AI-predicted activity ≥40% against K. pneumoniae, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 199
- Existing antimicrobials set aside
- 98
- Needing review
- 16
- Repurposing candidates
- 85
Repurposing candidates for K. pneumoniae
AI prediction · nothing measuredAll 85 repurposing candidates for K. pneumoniae.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Trametinib Dimethyl SulfoxideExisting use: Cancer, Cutaneous melanoma, Glioblastoma multiforme and 5 more44.6% AI-predicted activityagainst K. pneumoniae16 registered studies
- GrazoprevirExisting use: Chronic hepatitis C virus infection44.6% AI-predicted activityagainst K. pneumoniae50+ registered studies
- TacrolimusExisting use: Atopic eczema, Delayed Graft Function, Eczematoid dermatitis and 3 more44.4% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Prasugrel HydrochlorideExisting use: Acute coronary syndrome, Hemorrhage, Intermediate coronary syndrome and 1 more44.4% AI-predicted activityagainst K. pneumoniae50+ registered studies
- PosaconazoleExisting use: Aspergillosis, Candidiasis, Coccidioidomycosis and 2 more44.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Baloxavir MarboxilExisting use: Influenza, Viral disease44.0% AI-predicted activityagainst K. pneumoniae24 registered studies
- RivaroxabanExisting use: Acute coronary syndrome, Atrial fibrillation, Coronary artery disease and 9 more43.6% AI-predicted activityagainst K. pneumoniae50+ registered studies
- LevoleucovorinExisting use: Anemia, Colorectal adenocarcinoma, Colorectal cancer and 3 more43.6% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Leucovorin CalciumExisting use: Osteosarcoma43.6% AI-predicted activityagainst K. pneumoniae50+ registered studies
- PaliperidoneExisting use: Mental or behavioural disorder, Psychosis, Schizoaffective disorder and 1 more43.4% AI-predicted activityagainst K. pneumoniae50+ registered studies
- RisperidoneExisting use: Aggressive behavior, Autism, Bipolar disorder and 4 more43.3% AI-predicted activityagainst K. pneumoniae50+ registered studies
- SirolimusExisting use: Adenoma sebaceum, Angiofibroma, Cancer and 5 more43.1% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Pipecuronium BromideExisting use: Other quaternary ammonium compounds42.9% AI-predicted activityagainst K. pneumoniae5 registered studies
- Fosaprepitant DimeglumineExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more42.9% AI-predicted activityagainst K. pneumoniae21 registered studies
- CabergolineExisting use: Hypothalamic neoplasm, Parkinson disease42.8% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Fondaparinux SodiumExisting use: Deep vein thrombosis, Intermediate coronary syndrome, Myocardial infarction and 3 more42.7% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Zavegepant HydrochlorideExisting use: Migraine disorder42.6% AI-predicted activityagainst K. pneumoniaeNo documented evidence found
- ApalutamideExisting use: Cancer, Metastatic prostate cancer, Neoplasm and 3 more42.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Vecuronium BromideExisting use: Other quaternary ammonium compounds42.0% AI-predicted activityagainst K. pneumoniae50+ registered studies
- Lenacapavir SodiumExisting use: HIV infection, HIV-1 infection, Viral disease42.0% AI-predicted activityagainst K. pneumoniaeNo documented evidence found
- Lumateperone TosylateExisting use: Psychosis, Schizophrenia41.9% AI-predicted activityagainst K. pneumoniae6 registered studies
- RepotrectinibExisting use: Cancer, Neoplasm41.8% AI-predicted activityagainst K. pneumoniae17 registered studies
- MoxidectinExisting use: Helminthiasis, Onchocerciasis41.7% AI-predicted activityagainst K. pneumoniae25 registered studies
- PralsetinibExisting use: Cancer, Medullary thyroid gland carcinoma, Neoplasm and 1 more41.5% AI-predicted activityagainst K. pneumoniae19 registered studies